Lemonade stock: why recent returns have investors reassessing risk and growth

Lemonade (LMND) has drawn fresh attention after a recent pullback, with the share price showing a 7.4% decline over the past week and a 29.5% decline over the past 3 months.

While the recent 7 day share price return of negative 7.4% and 3 month share price return of negative 29.5% point to fading short term momentum, the 1 year total shareholder return of 122.5% and 3 year total shareholder return of more than 5x suggest earlier optimism around Lemonade’s growth potential and risk profile is still a major part of the story.

If you are comparing Lemonade with other fast changing opportunities, this is a good moment to broaden your search and check out 19 top founder-led companies

With Lemonade still loss making on US$737.9 million of revenue and trading close to analyst price targets, the recent pullback raises a simple question for you: is there real value left here, or is the market already pricing in future growth?

Most Popular Narrative: 14.8% Undervalued

Lemonade’s most followed valuation narrative pegs fair value at $77.14 per share, above the last close of $65.71. This frames the recent pullback in a different light.

Lemonade reported in-force premiums of $889 million, up 24% year over year and higher by nearly 50% since mid-2022. The company now has 2.31 million customers, up 17% from year-ago levels, and gross profit climbed 71%.

Want to see what justifies a higher fair value than today’s price? The narrative highlights rapid premium growth, rising gross profit, and a future profit profile that assumes meaningful margin expansion.

Result: Fair Value of $77.14 (UNDERVALUED)

However, there are real risks here, including ongoing net losses of US$165.5 million and the possibility that growth in car or other lines slows or that the company misprices risk.

Another view: multiples tell a tougher story

The popular narrative points to a fair value of $77.14 per share and a 14.8% undervaluation, but the current P/S ratio of 6.8x paints a different picture. That is far above the estimated fair ratio of 1.5x, the US Insurance industry average of 1.1x, and the peer average of 1.9x.

In plain terms, the market is already paying a much higher price for each dollar of Lemonade’s revenue than for many insurance peers. This can mean less room for error if growth or profitability progress slows. Which story do you think better reflects the risk you are willing to take?

Next Steps

Debates like this show how split sentiment can be around the same set of numbers. Move quickly, review the data yourself, and weigh 2 key rewards and 1 important warning sign

Looking for more investment ideas?

If Lemonade has caught your attention, do not stop here. Broaden your watchlist now so you are not relying on a single story or sector.

• Target potential mispricings by scanning a curated set of 56 high quality undervalued stocks that combine quality fundamentals with attractive valuations.
• Build a sturdier core portfolio by reviewing companies in the solid balance sheet and fundamentals stocks screener (42 results) that may better handle tough conditions.
• Stay a step ahead by hunting through a screener containing 24 high quality undiscovered gems that many investors might not be watching yet.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.